Sullivan Lara 4
4 · Pyxis Oncology, Inc. · Filed Jan 3, 2023
Insider Transaction Report
Form 4
Sullivan Lara
DirectorPresident ,CEO & CMO
Transactions
- Award
Common Stock
2023-01-03+95,684→ 1,452,320 total
Footnotes (1)
- [F1]Represents restricted stock units that vest on April 13, 2023, subject to the Reporting Person's continued employment through the vesting date.